H.R. 6130 House Health
ASAP Act
Committee Consideration, still liveSTAGE 2 OF 8 — COMMITTEE CONSIDERATION
Currently in the House. Last action: ordered to be reported in the nature of a substitute by the yeas and nays: 40 - 0 on Sep 16, 2026.
- House Introduced in House Nov 19, 2025
- House Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. Nov 19, 2025
- House Committee Consideration and Mark-up Session Held Sep 16, 2026
- House Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 40 - 0. Sep 16, 2026
Cosponsors
239
Subjects
Blood and blood diseasesHealth care coverage and accessMedical tests and diagnostic methodsMedicareNeurological disorders
Committees
- Ways and Means Committee
- [Markup By, Sep 16, 2026]
- [Referred To, Nov 19, 2025]
- Energy and Commerce Committee
- [Referred To, Nov 19, 2025]
Summary
Alzheimer's Screening and Prevention Act of 2025 or the ASAP ActThis bill provides for Medicare coverage of blood tests to screen for the early stages of Alzheimer’s disease or related dementias. Specifically, the bill provides for coverage of genomic sequencing blood or blood product tests, or other equivalent tests, that are approved by the Food and Drug Administration.
[Summary as of: Introduced in House]
Comments · 0
Please log in to post a comment.
Loading comments...